Foundry Calendar

Foundry Calendar

May 11, 2026
  • 5:00 pm - 7:00 pm *Foundry* Office Hours: Courtyard Ventures

    Location: https://berkeley.zoom.us/j/95760061449


    | Description:

    SIGN UP HERE

    Courtyard Venture Fund I is a $5M fund focused on investing in startups from Berkeley. Courtyard provides an avenue for Berkeley students and alumni to invest in new ventures started by their peers, increasing the amount of early-stage capital in the startup ecosystem. In close partnership with the school and students, we have unprecedented access to new ventures founded by Berkeley entrepreneurs and will seek to make smart investments in startups that will benefit from the people, resources, and network of a top-tier university.


May 21, 2026
  • 9:00 pm - 11:00 pm *Foundry* Office Hours - WilmerHale Legal


    | Description:

    SIGN UP HERE

    Ashwin Gokhale helps public and private technology companies navigate through technology transactions and licensing matters. He draws on his prior experience leading a legal team at a high-growth venture-backed company and his business experience working for various other startups in Silicon Valley to provide practical solutions to the legal and business challenges his clients face.

    Molly Holsinger is a corporate senior associate who represents public and private companies in mergers and acquisitions, technology transactions, and venture capital and private equity financings.


May 22, 2026
  • 9:00 pm - 10:30 pm *Foundry* Office Hours: Carr & Ferrell LLP [Legal/Strategy]


    | Description:

    SIGN UP HERE

    Office hours with counsel from Carr & Ferrell LLP 

    -- Brian Bathurst --

    Brian is Senior Counsel in the Intellectual Property Practice Group of Carr & Ferrell. Brian's experience includes patent and trademark prosecution, litigation and licensing.

    Brian has extensive experience in several technological areas including biotechnology, pharmaceutical, medical device, hardware, software and e-commerce. Prior to practicing law, Brian held positions of increasing responsibility in the biochemical manufacturing, clinical research and strategic operations groups for Genentech, Inc. Having worked on the product development and market launches of Activase®, Nutropin®, Pulmozyme®, Actimmune® and Herceptin®, Brian's biopharmaceutical clients benefit from his industry experience.